Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

TNF-alpha inhibitors can cause various immune-related skin issues.

Clascoterone may be an effective topical treatment for hair loss.

Finasteride reduces some inflammation in BPH but not all.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Blocking certain immune signals can reduce skin damage from radiation therapy.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.